Rs Crum Inc. Amgen Inc Transaction History

Rs Crum Inc.

$350 Million
Q1 2024

A detailed history of Rs Crum Inc. transactions in Amgen Inc stock. As of the latest transaction made, Rs Crum Inc. holds 2,300 shares of AMGN stock, worth $718,635. This represents 0.19% of its overall portfolio holdings.

Number of Shares

2,300

Previous 2,301 0.04%

Holding current value

$718,635

Previous $662,000 1.36%

% of portfolio

0.19%

Previous 0.21%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$268.87 - $324.56 $268 - $324	-1 Reduced 0.04%	2,300 $653,000
Q4 2023 Feb 12, 2024	BUY	$255.7 - $288.46 $255 - $288	1 Added 0.04%	2,301 $662,000
Q2 2023 Aug 09, 2023	SELL	$214.27 - $253.37 $15,427 - $18,242	-72 Reduced 3.04%	2,300 $510,000
Q1 2023 Aug 11, 2023	SELL	$225.79 - $275.2 $225 - $275	-1 Reduced 0.04%	2,303 $556,000
Q4 2022 Aug 11, 2023	BUY	$229.03 - $291.01 $916 - $1,164	4 Added 0.17%	2,304 $605,000

Q1 2022 Apr 21, 2022	BUY	$219.27 - $242.57 $219 - $242	1 Added 0.04%	2,372 $574,000
Q4 2021 Feb 22, 2022	BUY	$198.88 - $227.6 $471,544 - $539,639	2,371 New	2,371 $533,000

Others Institutions Holding AMGN

# of Institutions

2,930

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $167B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rs Crum Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rs Crum Inc. with notifications on news.

Account